Fibroblast growth factors and their receptors: An information network controlling tissue growth, morphogenesis and repair

Progress in Growth Factor Research

Volumn 5, Issue 4, 1994, Pages 353-377

  Fernig, David G ^a   Gallagher, John T ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

dual receptor; FGF; FGFR; HSPG

Indexed keywords

CELL SURFACE RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL; GENETICS; HUMAN; METABOLISM; MORPHOGENESIS; PHYSIOLOGY; REVIEW;

ANIMAL; FIBROBLAST GROWTH FACTORS; HUMAN; MORPHOGENESIS; RECEPTORS, CELL SURFACE; RECEPTORS, FIBROBLAST GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T;

EID: 0028252684     PISSN: 09552235     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-2235(94)00007-8     Document Type: Article

References (193)

1. Can regulatory peptides be regarded as words of a biological language
2. Complete primary structure of prostatropin, a prostate epithelial cell growth factor
3. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF
4. Localisation of fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth
5. Human endothelial cell growth factor: Cloning, nucleotide sequence and chromosome localization
6. Brain and pituitary fibroblast growth factor activities behave identically on three independent high performance liquid chromatography systems
7. Growth control and mitogenic response in cultured fibroblasts: Induction of the pleiotypic and mitogenic response by a purified growth factor
8. Factors involved in the modulation of cell proliferation in vivo and in vitro: The role of fibroblast and epidermal growth factors in the proliferative response of mammalian cells
9. Molecular and biological characterization of fibroblast growth-factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells
10. The presence of fibroblast growth factor in the frog egg: its role as a natural mesoderm inducer
11. Inductive effects of FGF and lithium ion on Xenopus blastula ectoderm
12. Appearance of basic fibroblast growth factor receptors upon differentiation of rat mammary epithelial to myoepithelial-like cells in culture
13. Mitogenic activity of pituitary hormones on cell cultures of normal and carcinogen-induced tumor epithelium from rat mammary glands
14. Different growth factors stimulate cell division of rat mammary epithelial, myoepithelial, and stromal cell lines in culture
15. Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers and dystrophic muscle
16. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo
17. Fibroblast growth factors: From genes to clinical applications
18. BEK and FLG, two receptors to members of the FGF family are amplified in subsets of human breast cancers
19. Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease
20. Ectopic production of heparin-binding growth factors and receptors for basic fibroblast growth factor by rat mammary epithelial cell lines derived from malignant metastatic tumours
21. Growth factors and tyrosine protein kinases in normal and malignant melanocytes
22. K-sam, an amplified gene in stomach cancer is a member of the heparinbinding growth factor receptor genes
23. The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas
24. Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues
25. bFGF binding sites in human breast cancer
26. Basic fibroblast growth-factor (bFGF) — mitogenic activity and binding-sites in human breast cancer
27. Amplification of FGF-related genes in human tumors: Possible involvement of HST in breast carcinomas
28. Normal and malignant human colonic mucosa contain acidic and basic fibroblast growth factors
29. Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons
30. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons
31. Subcellular fate of the int-2 oncoprotein is determined by choice of initiation codon
32. Three forms of rat basic fibroblast growth factor are made from a single messenger RNA and localize to the nucleus
33. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species
34. Basic fibroblast growth factor accumulates in the nuclei of various bFGFproducing cell types
35. Crystal structure of basic fibroblast growth factor at 1.6 Å resolution
36. Three-dimensional structure of human basic fibroblast growth factor
37. Three-dimensional structures of acidic and basic fibroblast growth factors
38. Synthesis of basic fibroblast growth factor upon differentiation of rat mammary epithelial to myoepithelial-like cells in culture
39. Enhancement of anchorage-independent growth of a human adrenal carcinoma cell line by endogenously produced basic fibroblast growth factor
40. The expression of basic fibroblast growth factor and its receptor in cell lines derived from normal human mammary gland and a benign mammary lesion
41. Expression of multiple species of basic fibroblast growth factor mRNA and protein in normal and tumor-derived mammary epithelial cells in culture
42. Elevated expression of basic fibroblast growth factor messenger ribonucleic acid in acoustic neuromas
43. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T
44. Cloning and expression of cDNA encoding human basic fibroblast growth factor
45. Gene structure and differential expression of acidic fibroblast growth factor messenger RNA - identification and distribution of 4 different transcripts
46. Cloning of 2 novel forms of human acidic fibroblast growth factor (aFGF) messenger RNA
47. An antisense mRNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes
48. An antisense transcript from the Xenopus laevis bFGF gene coding for an evolutionary conserved 24 kd protein
49. Signal transduction by receptors with tyrosine kinase activity
50. Flg-2, a new member of the family of fibroblast growth factor receptors
51. Related fibroblast growth factor receptor genes exist in the human genome
52. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3
53. Identification of a developmentally regulated protein-tyrosine kinase by using anti-phosphotyrosine antibodies to screen a cDNA expression library
54. FGFR4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern
55. 5 FGF receptors with distinct expression patterns
56. Fibroblast growth factor receptor tyrosine kinases — molecular analysis and signal transduction
57. Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction
58. A novel form of fibroblast growth factor receptor-2 — alternative splicing of the 3rd immunoglobulin-like domain confers ligand binding specificity
59. A naturally occurring secreted form of fibroblast growth factor (FGF) receptor-1 binds basic FGF in preference over acidic FGF
60. Alternative splicing generates at least five isoforms of the human basic-FGF receptor
61. The expression of 2 isoforms of the human fibroblast growth factor receptor (fig) is directed by alternative splicing
62. Fibroblast growth factor receptors from liver vary in 3 structural domains
63. Multiple messenger RNAs code for proteins related to the BEK fibroblast growth factor receptor
64. Different members of the fibroblast growth factor receptor family are specific to distinct cell types in the developing chicken embryo
65. The structure and expression of the FGF receptor-1 messenger RNA isoforms in rat tissues
66. Expression of two different forms of fibroblast growth factor receptor-1 in different mouse tissues and cell lines
67. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas
68. Expression and transforming activity of a variant of the heparin-binding fibroblast growth factor receptor (flg) gene resulting from splicing of the alpha exon at an alternate 3′ acceptor site
69. Differential splicing in the extracellular region of fibroblast growth factor receptor-1 generates receptor variants with different ligand-binding specificities
70. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains
71. The human fibroblast growth factor receptor genes — a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain
72. Determination of ligand-binding specificity by alternative splicing — two distinct growth factor receptors encoded by a single gene
73. A confined variable region confers ligand specificity on fibroblast growth factor receptors — implications for the origin of the immunoglobulin fold
74. Multiple structural elements determine ligand binding of fibroblast growth factor receptors — evidence that both Ig domain-2 and domain-3 define receptor specificity
75. Characterization of the murine BEK fibroblast growth factor (FGF) receptor — activation by 3 members of the FGF family and requirement for heparin
76. Structure and function of heparan sulphate proteoglycans
77. Proteoglycans: Structures and Interactions
78. Biology of the syndecans: A family of transmembrane heparan sulphate proteoglycans
79. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulphate proteoglycan from human lung fibroblasts
80. Cerebroglycan: An integral membrane heparan sulphate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation
81. Binding of two growth factor families to separate domains of the proteoglycan Betaglycan
82. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan sulphate intrinsic membrane proteoglycan with additional exons
83. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan) — a chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor
84. Patterns of sulphation in heparan sulphate — polymorphism based on a common structural theme
85. Heparan sulphates as membrane receptors for the fibroblast growth factors
86. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulphate
87. Minimal sequence in heparin/heparan sulphate required for binding of basic fibroblast growth factor
88. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: Implications for a role of heparinase-like enzymes in the neovascular response
89. Immunolocalisation of basic fibroblast growth factor during chicken cardiac development
90. Expression of basic fibroblast growth factor in normal human tissues
91. Acidic fibroblast growth factor in the developing rat embryo
92. Distribution of basic fibroblast growth factor in the 18-day rat fetus: Localization in the basement membranes of diverse tissues
93. Localisation of basic fibroblast growth factor and transforming growth factor beta-1 in the human mammary gland
94. Biochemical and ultrastructural evidence for the association of basic fibroblast growth factor with cardiac gap junctions
95. Immunocytochemical identification of basic fibroblast growth factor in the developing rat mammary gland: Variations in location are dependent on glandular structure and differentiation
96. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix
97. Immunolocalization of basic fibroblast growth factor — dependence on antibody type and tissue fixation
98. Transformed phenotype conferred to NIH/3T3 cells by ectopic expression of heparin-binding growth factor-1 acidic fibroblast growth factor
99. Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential
100. A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression
101. Release of basic fibroblast growth factor devoid of secretory signal sequence — a trivial phenomenon or a novel secretion mechanism
102. Cellular and molecular adaptations to injurious mechanical stress
103. Modes of FGF release in vivo and in vitro
104. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells
105. Growth-factors are released by mechanically wounded endothelial-cells
106. Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells
107. Heat shock induces the release of fibroblast growth factor-1 from NIH-3T3 cells
108. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner
109. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex
110. A novel secretory pathway for interleukin-l-beta, a protein lacking a signal sequence
111. 3. Role of theINT-genes in murine mammary tumor development and implications for human breast cancer
112. Detection and characterization of the fibroblast growth factor-related oncoprotein INT-2
113. The int-2 gene product acts as an epithelial growth factor in transgenic mice
114. Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants
115. Modulation of bFGF action by low-affinity receptors in rat mammary myoepithelial-like cells in culture
116. Role of extracellular matrix in the action of basic fibroblast growth factor: Matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis
117. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form
118. Basic fibroblast growth factor-syndecan complex at cell surface or immobilized to matrix promotes cell growth
119. Nature of the interaction of heparin with acidic fibroblast growth factor
120. Basic fibroblast growth factor (bFGF) disssociates rapidly from heparan sulfates but slowly from receptors — implications for mechanisms of bFGF release from pericellular matrix
121. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding
122. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix — a permissive role of cathepsin-D
123. Extracellular sequestration and release of fibroblast growth factor — a regulatory mechanism
124. Extracellular matrix-resident growth factors and enzymes — possible involvement in tumor metastasis and angiogenesis
125. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells
126. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan — a mechanism for cooperativity
127. High and low affinity binding of heparin-binding growth factor to a 130 kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell
128. Identification of heparan sulfate proteoglycan as a high affinity receptor for acidic fibroblast growth factor (aFGF) in a parathyroid cell line
129. A dual receptor system is required for basic fibroblast growth factor activity
130. FDC-P1 myeloid cells engineered to express fibroblast growth factor receptor-1 proliferate and differentiate in the presence of fibroblast growth factor and heparin
131. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation
132. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
133. High-affinity NGF binding requires coexpression of the Trk proto-oncogene and the low-affinity NGF receptor
134. Activating and inhibitory heparan sequences for FGF-2 (basic FGF)
135. Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor
136. Specific heparan sulphate saccharides mediate the activity of basic fibroblast growth factor
137. Repression of myogenic differentiation by aFGF, bFGF and K-FGF is dependent on cellular heparan sulfate
138. Ligand specificity and heparin dependence of fibroblast growth factor receptor-1 and receptor-3
139. Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor
140. Effect of heparin on the binding affinity of acidic FGF for the cloned human FGF receptors, flg and bek
141. Binding of heparin to basic fibroblast growth factor induces a conformational change
142. Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor
143. An essential Heparin-binding domain in the fibroblast growth factor receptor kinase
144. Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulphate proteoglycan
145. Activation of basic fibroblast growth factor (bFGF) by heparan sulphate (HS)
146. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor
147. Fibroblast growth factor-2 (FGF-2) in the nucleus — translocation process and targets
148. Binding, internalization, and degradation of basic fibroblast growth factor in human microvascular endothelial cells
149. Immunolocalization of basic fibroblast growth factor (bFGF) in growing and growth-inhibited placental cells — a possible role for bFGF in placental cell development
150. Translocation of bFGF to the nucleus is Gl phase cell-cycle specific in bovine aortic endothelial-cells
151. Basic fibroblast growth-factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0-G1 transition
152. Internalization and processing of basic fibroblast growth factor by neurons and astrocytes
153. Nuclear translocation of fibroblast growth factor during Xenopus mesoderm induction
154. A 16-kilodalton heparin binding (fibroblast) growth factor type one appears in a stable 40-kilodalton complex after receptor-dependent internalisation
155. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations
156. Recovery of mitogenic activity of a growth-factor mutant with a nuclear translocation sequence
157. Identification of a heparin-binding growth factor-1 nuclear translocation sequence by deletion mutation analysis
158. Dual mode of signal transduction by externally added acidic fibroblast growth factor
159. Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH 3T3 cells
160. The mitogen-activated protein kinase signal transduction pathway
161. Signalling by receptor tyrosine kinases
162. The insulin signaling system.
163. Ligand-induced transphosphorylation between different FGF receptors
164. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy.
165. The major acidic fibroblast growth factor (aFGF)-stimulated phosphoprotein from bovine liver plasma membranes has aFGF-stimulated kinase, autoadenylylation, and alkaline nucleotide phosphodiesterase activities
166. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis
167. 2+ flux but not mitogenesis
168. Human epidermal growth factor and the proliferation of human fibroblasts
169. The timing of late signals for initiation of the cell cycle in fibroblasts
170. The labile nature of the insulin signal for the stimulation of DNA synthesis in mouse lens epithelial and 3T3 cells
171. Action of growth factors in the cell
172. An ordered sequenced of events is required before Balb/c-3T3 cells become committed to DNA synthesis
173. Evidence that biphasic effects of basic fibroblast growth factor on 5-ene-3 beta-hydroxysteroid dehydrogenase-isomerase activity in cultured immature leydig cells are mediated by binding to heparan sulfate proteoglycans
174. Basic fibroblast growth factor-induced increase in 125I-human chorionic gonadotropin binding to luteinizing hormone receptors in cultured immature leydig cells is mediated by binding to heparan sulfate proteoglycans
175. cis-Acting elements involved in the alternative translation initiation process of human basic fibroblast growth factor messenger RNA
176. Liver heparan sulfate structure — a novel molecular design
177. Heparan-sulfate bound growth-factors — a mechanism for stromal cell-mediated hematopoiesis
178. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
179. A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine
180. Heregulin induces tyrosine phosphorylation of HER4/p180(erbB4)
181. Interferon-gamma binds to heparan-sulfate by a cluster of amino-acids located in the C-terminal part of the molecule
182. Interaction of hepatocyte growth factor with heparan sulfate — elucidation of the major heparan sulfate structural determinants
183. Transforming growth factor-beta-1 is a heparin-binding protein — identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta-1
184. Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences
185. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules
186. Sequence, topography and protein coding potential of mouse int-2: A putative oncogene activated by mouse mammary tumor virus
187. An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family
188. Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2 encoded protein
189. The human FGF-5 gene encodes a novel protein related to fibroblast growth factors
190. Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor family
191. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth
192. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells.
193. Molecular cloning of a novel cytokine cDNA encoding the 9th member of the fibroblast growth factor family, which has a unique secretion property